Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced the presentation of ...

In this Cut for Time sketch, a scientist (Colin Jost) joins a news broadcast to discuss a new strain of the Epstein–Barr virus.

The Epstein-Barr virus behind mono, which spreads through saliva, sits silently in the body but can reactivate.

Barr virus (EBV) are very common; the virus is estimated to have infected at least 90% of all adults worldwide... | Genetics And Genomics ...

Use BBC.com or the new BBC App to listen to BBC podcasts, Radio 4 and the World Service outside the UK.

Vaccination is one of the greatest achievements in immunology and medicine, nearly eradicating many infectious diseases that ...

An Anglo-American team of researchers has devised a new computational method for quantifying Epstein-Barr virus (EBV) ...

Infectious mononucleosis is most often caused by the Epstein-Barr virus (EBV), a member of the herpes virus family. Less ...

Nine in 10 people worldwide have been infected with Epstein-Barr virus (EBV). | Nine in 10 people worldwide have been ...

This could spell relief for untold millions.

The study's findings suggest that health outcomes reflect a complex interaction between genes, lifestyle, and viral history ...

Moderna (NasdaqGS:MRNA) is shifting away from self-funding new Phase III vaccine trials in response to increased vaccine ...